Tue, September 14, 2021
Mon, September 13, 2021
Fri, September 10, 2021

Jonathan Chang Maintained (ADAP) at Hold with Increased Target to $7 on, Sep 13th, 2021

Jonathan Chang of SVB Leerink, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Increased Target from $6 to $7 on, Sep 13th, 2021.

Jonathan has made no other calls on ADAP in the last 4 months.



There is 1 other peer that has a rating on ADAP. Out of the 1 peers that are also analyzing ADAP, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Peter Lawson of "Barclays" Initiated at Sell and Held Target at $4 on, Friday, May 28th, 2021